Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t(11;14)

Haematologica. 2020 Mar;105(3):e141-e143. doi: 10.3324/haematol.2019.228338. Epub 2019 Nov 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Humans
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / genetics
  • Renal Dialysis
  • Sulfonamides / therapeutic use

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • venetoclax